Summary
Congenital heart defects (CHDs) are the most common congenital malformation and will, in severe cases, have a serious impact on neonatal mortality and morbidity. The aetiology of CHDs is complex. Large cohort studies have reported an association between increased risk of CHDs in the offspring and individual maternal metabolic disorders such as diabetes, hypertension, preeclampsia, and obesity. All conditions that can be related to insulin resistance and possibly metabolic syndrome (MetS). The aim of this review is to evaluate the existing evidence on the association between maternal metabolic disorders, defined as obesity, diabetes, hypertension, preeclampsia, dyslipidaemia, and MetS, or combinations thereof and CHDs in the offspring. A literature search was performed using PubMed and Embase databases. Of the 2,076 potentially relevant identified studies, 30 qualified for inclusion. Only one study dealt with the combination of more than one maternal metabolic condition as risk factor for CHDs in the offspring. All other studies investigated the individual metabolic disorders and their association with CHDs. Some disorders (chronic hypertension, gestational diabetes, and obesity) increased risk of CHDs marginally whereas pregestational diabetes and early-onset preeclampsia were highly associated with CHDs. Future studies on the combination of several metabolic disorders in the same pregnancy and their association with CHDs are needed.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study was supported by The Danish Children Heart Foundation (18-R109-A5193-26043). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
No ethical approval was nescessary for this literature review.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
All data available on request to corresponding author.
Abbreviations
- CHDs
- congenital heart defects
- MetS
- metabolic syndrome
- PE
- preeclampsia
- BMI
- body mass index
- GDM
- gestational diabetes
- DM2
- diabetes type 2
- DM1
- diabetes type 1
- ICD-10
- International Classification of Diseases 10th revision
- NOS
- Newcastle-Ottawa Scale
- OR
- odds ratios
- RR
- relative risks
- PR
- prevalence ratios
- CI
- 95% confidence interval
- aOR/aRR/aPR
- adjusted
- AVSD
- atrioventricular septal defects
- RVOTO
- right ventricular outflow tract obstruction
- VSD
- ventricular septal defects
- ASD
- atrial septal defect
- NBDPS
- National Birth Defects Prevention Study
- CoA
- coarctation of the aorta